Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ryzodeg.
Phase of Trial: Phase IV
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Insulin degludec/insulin aspart (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 06 Sep 2016 Status changed from not yet recruiting to recruiting.
- 01 Jul 2016 New trial record